More about

Mitochondrial Dysfunction

News
March 28, 2025
5 min read
Save

Latest data show progress of GA therapies in the pipeline

The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: pegcetacoplan, or Syfovre, from Apellis Pharmaceuticals and avacincaptad pegol, or Izervay, from Astellas.

News
May 17, 2024
7 min read
Save

Push to ‘repair the mitochondria’ may revolutionize rheumatoid arthritis treatment

Last year, a presentation at the American College of Rheumatology Convergence provided a glimpse into a potential mechanism of inflammation in rheumatoid arthritis that may fundamentally alter treatment approaches.

News
April 26, 2024
1 min read
Save

Combination ALS therapeutic nonsuperior to placebo in phase 3 clinical trial

DENVER — A combination therapeutic for amyotrophic lateral sclerosis was nonsuperior to placebo over 48 weeks in a phase 3 clinical trial, according to a presenter at the American Academy of Neurology annual meeting.

News
January 11, 2024
1 min read
Save

EMA approves biomarker study of mitochondrial stimulator for neurodegenerative diseases

The European Medicines Agency has approved enrollment for a phase 1/2a biomarker study to examine a once-daily, oral, brain penetrant mitochondrial stimulator to treat a range of neurological and neuromuscular conditions.

News
August 09, 2023
2 min read
Save

Heart, other organs show mitochondrial damage after COVID-19 despite recovery of lungs

Following SARS-CoV-2 infection, mitochondrial function remained impaired in the heart, liver and kidneys, despite observed recovery in the lungs, according to a human autopsy and animal tissue study.

News
February 23, 2023
1 min read
Save

Retinal flavoprotein fluorescence could be new biomarker of AMD stage, progression

Mitochondrial flavoprotein fluorescence may possibly serve as an indicator of age-related macular degeneration stage, helping to detect early disease and offering insights on how and when to treat patients, according to a study.

News
August 23, 2022
1 min read
Save

Cell stress, mitochondrial dysfunction observed in early Alzheimer's patients

Researchers at Invicro have found evidence supporting cellular stress and bioenergetic abnormalities in patients with early-stage Alzheimer's disease, according to new data published in Science Translational Medicine.

News
March 03, 2022
3 min read
Save

Novel markers of resistant hypertension observed in Black patients

Xanthine oxidase and mitochondrial DNA damage-associated molecular patterns may represent novel biomarkers of resistant hypertension among Black patients, researchers reported.

News
February 14, 2020
3 min read
Save

Cocoa may improve walking ability in patients with PAD

Daily consumption of cocoa with epicatechin improved 6-minute walk distance, blood flow to the legs and skeletal muscle health in patients with peripheral artery disease, according to a study published in Circulation Research.

News
September 27, 2019
2 min read
Save

POAG associated with lower plasmatic nicotinamide levels

Primary open-angle glaucoma was found to be associated with lower plasmatic nicotinamide levels, and researchers suggest that the vitamin may have future therapeutic use.